Accuracy and prognostic significance of oncologists' estimates and scenarios for survival time in a randomised Phase 2 trial of regorafenib in advanced gastric cancer

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Vasista, A; Martin, A; Pavlakis, N; Sjoquist, K; Snow, S; Jonker, D; Chua, YJ; Epstein, R; Bonaventura, A; Khasraw, M; Varma, SC; Singhal, N; Ransom, DT; Aubin, F; Burkes, R; Lim, H; Lemay, F; Begbie, S; Stockler, MR; Kiely, B

Published Date

  • September 1, 2017

Published In

Volume / Issue

  • 28 /

Published By

Pages

  • 2

Electronic International Standard Serial Number (EISSN)

  • 1569-8041

International Standard Serial Number (ISSN)

  • 0923-7534

Conference Name

  • 42nd European-Society-for-Medical-Oncology Congress (ESMO)

Conference Location

  • Madrid, SPAIN

Conference Start Date

  • September 8, 2017

Conference End Date

  • September 12, 2017